Skip to content

Exercise Training and Testosterone Replacement in Heart Failure Patients

Exercise Training and Testosterone Replacement in Heart Failure Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01852994
Enrollment
39
Registered
2013-05-14
Start date
2009-07-31
Completion date
2015-07-31
Last updated
2016-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to determine if exercise training with or without testosterone replacement can improve cardiopathy in heart failure patients

Detailed description

In this study, we are evaluating: * hospital length of stay and readmission * muscle sympathetic nerve activity * functional capacity * body composition

Interventions

Application quarterly of Testosterone Undecylate

OTHERExercise training

Aerobic and strength exercise training

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* heart failure * hypogonadism * left ventricular fraction ejection \< 45%

Exclusion criteria

* chronic renal failure * normal testosterone * pace maker

Design outcomes

Primary

MeasureTime frameDescription
Microneurography4 months of exercise training/testosterone replacementMuscle sympathetic nerve activity (MSNA) is recorded directly from the peroneal nerve using the microneurography technique. Multiunit postganglionic muscle sympathetic nerve recordings is made using a tungsten microelectrode. All of the recordings of MSNA met previously established and described criteria. MSNA is quantified as burst frequency (bursts per minute).
Forearm blood flow4 months of exercise training/testosterone replacementForearm blood flow is measured by venous occlusion plethysmography. The nondominant arm is elevated above heart level to ensure adequate venous drainage. A mercury-filled silastic tube attached to a low-pressure transducer is placed around the forearm and connected to a plethysmography. Forearm blood flow is determined on the basis of a minimum off four separate readings. Forearm vascular conductance is calculated by dividing forearm blood flow by mean arterial pressure times 100 and expressed in arbitrary units.

Secondary

MeasureTime frameDescription
Body composition4 months of exercise training/testosterone replacementBody composition and bone mineral density is determined by dual energy x-ray absorptiometry using densitometry equipment (Hologic), at the following regions: lumbar spine, femoral neck, total femur and total body. Appendicular lean mass is calculated as the sum of arms and legs lean soft tissue masses, assuming that all non-fat and non-bone tissue is skeletal muscle. The total body fat is expressed in grams and as a percentage of body weight.
Cardiopulmonary exercise4 months of exercise training/testosterone replacementThe maximal cardiopulmonary test is carried out on a bike using a ramp protocol with workload increment every minute with energetic demand of about 1 metabolic equivalent(MET) per minute or 3.5 mL/Kg.min of oxygen uptake.
Muscle biopsy4 months of exercise training/testosterone replacementThe muscle biopsy is obtained with a single entry into the muscle 5-10 minutes after administering the local anesthetic following an incision through the skin. A portion of the muscle (\ 10 mg) is processed to evaluate 1) muscle fiber type and 2) cross-sectional area

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026